Tempest Therapeutics (TPST) Assets (2011 - 2026)
Tempest Therapeutics (TPST) posted Assets of $16.9 million for Q4 2025, down 1.16% sequentially from $17.1 million in Q3 2025, and down 59.19% YoY from $41.5 million in Q4 2024.
Tempest Therapeutics (TPST) Assets (2011 - 2026) Analysis & Trends
Tempest Therapeutics has reported Assets for 15 years, with the latest figure at $16.9 million in Q4 2025.
- Quarterly Assets fell 59.19% year-over-year to $16.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $16.9 million (down 59.19% YoY) and the FY2025 annual result came in at $16.9 million, down 59.19% from the prior year.
- Assets declined to $16.9 million in Q4 2025 per TPST's latest filing, from $17.1 million in the prior quarter.
- Over five years, Assets peaked at $75.5 million in Q2 2021 and troughed at $16.9 million in Q4 2025.
- A 5-year average of $46.6 million and a median of $43.3 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2021 and 2023: Assets jumped 220.33% in 2021, then plunged 62.03% in 2023.
- Over 5 years, Assets stood at $73.2 million in 2021, then plunged by 37.07% to $46.1 million in 2022, then advanced by 11.96% to $51.6 million in 2023, then decreased by 19.6% to $41.5 million in 2024, then plunged by 59.19% to $16.9 million in 2025.
- According to Business Quant data, Assets over the past three periods registered $16.9 million, $17.1 million, and $24.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Tempest Therapeutics | 4.32 Mn | 3.52 Mn | - | 9.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.63 Mn |
| Dec 31, 2025 | 16.93 Mn |
| Sep 30, 2025 | 17.13 Mn |
| Jun 30, 2025 | 24.48 Mn |
| Mar 31, 2025 | 32.16 Mn |
| Dec 31, 2024 | 41.49 Mn |
| Sep 30, 2024 | 33.84 Mn |
| Jun 30, 2024 | 42.17 Mn |
| Mar 31, 2024 | 44.38 Mn |
| Dec 31, 2023 | 51.60 Mn |
| Sep 30, 2023 | 23.99 Mn |
| Jun 30, 2023 | 30.74 Mn |
| Mar 31, 2023 | 37.33 Mn |
| Dec 31, 2022 | 46.09 Mn |
| Sep 30, 2022 | 63.17 Mn |
| Jun 30, 2022 | 71.35 Mn |
| Mar 31, 2022 | 66.95 Mn |
| Dec 31, 2021 | 73.24 Mn |
| Sep 30, 2021 | 67.14 Mn |
| Jun 30, 2021 | 75.50 Mn |